Review
Jul 2026
Lung Cancer Biomarker Testing: IHC, Tissue Genomics, Digital Pathology, and ctDNA.
Testing for predictive biomarkers in lung cancer has evolved to integrate immunohistochemistry, tissue-based next-generation sequencing (NGS), and liquid biopsy, and advances in digital pathology and AI promise novel biomarker discovery and integration into clinical practice.
Humberto E. Trejo Bittar, S. Dacic
· Cancer Journal · 0 citations